Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ CellSensor™ irf1-bla Ba/F3 Cell Line

Catalog No. K1654
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 Vial
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
K1654 1 Vial
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. K1654 Supplier Thermo Scientific™ Supplier No. K1654
Only null left
Add to Cart
Add to Cart
Request a Quote

Jak/Stat signaling pathways play essential roles in the cellular responses to distinct cytokines.

Jak/Stat signaling pathways play essential roles in the cellular responses to distinct cytokines. One of the Jak/Stat pathways, Jak2/Stat5, mediates cell proliferation in response to Interleukin-3 (IL-3), prolactin, erythropoietin (Epo), and granulocyte - macrophage colony stimulating factor (GM-CSF). JAK2 gene knockout causes embryonic lethality due to defective erythropoiesis, suggesting that the Jak2/Stat5 pathway plays an important role in red blood cell formation. The recent discovery of an activating mutation in JAK2 (V617F) present in a high percentage of myeloproliferative disease (MPD) patients suggests that the Jak2/Stat5 pathway may be a potential therapeutic target for certain forms of MPD. The activated Stat5 transcription factor recognizes and binds to a specific palindromic DNA sequence found in the promoter region of β-casein, interferon regulatory factor-1 (irf-1), and a number of other genes.

The CellSensor™ irf1-bla BA/F3 Cell Line contains a beta-lactamase reporter gene under control of the irf-1 response element stably integrated into BA/F3 cells. This cell line is validated for EC50 and Z' - factor under optimized conditions using mouse IL-3 (mIL-3). This cell line has also been tested under variable experimental conditions, including DMSO concentration, cell number, stimulation time, and substrate loading time. Responsiveness to Jak Inhibitor 1, a small molecule inhibitor, was also tested. CellSensor™ irf1-bla BA/F3 cells were treated with mIL-3 in triplicate over the indicated concentration range in a 384-well format. Cells were incubated for 5 hr. with mIL-3 agonist in 0.5% DMSO and then combined with LiveBLAzer™-FRET B/G Substrate (CCF4-AM) for 2.5 hr. Fluorescence emission values at 460 nm and 530 nm were obtained using a standard fluorescence plate reader. The Response Ratios for each replicate were plotted against the indicated concentrations of mIL-3. CellSensor™ irf1-bla BA/F3 cells were treated with Jak Inhibitor 1 for 30 min over the indicated concentration range in a 384 - well format. Cells were then incubated with mIL - 3 agonist in 0.5% DMSO for 5 hr. and then combined with LiveBLAzer™ - FRET B/G Substrate (CCF4-AM) for 2.5 hr. Fluorescence emission values at 460 nm and 530 nm were obtained using a standard fluorescence plate reader. The emission ratios were plotted against the indicated concentrations of Jak Inhibitor 1. Academic and non-profit customers, please inquire for special pricing.

TRUSTED_SUSTAINABILITY

Specifications

Assay Entry Cell-based beta lactamase reporter gene
Cell State Dividing Cells
Content And Storage CellSensor™ Cell Lines are shipped on dry ice. Store in liquid nitrogen immediately upon receipt, or thaw for immediate use.
Product Line CellSensor
Quantity 1 Vial
Target Entry STAT5, JAK/STAT (IL-3) pathway, JAK2
System Type CellSensor™
Druggable Target Signaling Pathway

For Research Use Only. Not for use in diagnostic procedures.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.